Cost-Effectiveness of Introducing Pneumococcal Vaccination Programme | Including: Economic Burden of Pneumococcal Diseases and Acute Otitis Media

Syed Mohamed Aljunid (u. a.)

ISBN 10: 3330973471 / ISBN 13: 9783330973473

Published by Noor Publishing, 2017

About this Item

Cost-Effectiveness of Introducing Pneumococcal Vaccination Programme | Including: Economic Burden of Pneumococcal Diseases and Acute Otitis Media | Syed Mohamed Aljunid (u. a.) | Taschenbuch | 216 S. | Englisch | 2017 | Noor Publishing | EAN 9783330973473 | Verantwortliche Person für die EU: preigu GmbH & Co. KG, Lengericher Landstr. 19, 49078 Osnabrück, mail[at]preigu[dot]de | Anbieter: preigu.

Seller Inventory # 109400849

Bibliographic Details

• Title: Cost-Effectiveness of Introducing Pneumococcal Vaccination Programme | Including: Economic Burden of Pneumococcal Diseases and Acute Otitis Media
• Publisher: Noor Publishing
• Publication Date: 2017
• Language: English
• ISBN 10: 3330973471
• ISBN 13: 9783330973473
• Binding: Taschenbuch
• Condition: Neu
• Dimensions: 220W x 150H x 14D millimeters 220 millimeters width by 150 millimeters height by 14 millimeters depth
• Weight: 340 grams
• Seller catalogs:
  • Bücher

About this title

Synopsis

Pneumococcal disease is one of the important public health issues worldwide. The World Health Organisation estimates that 1.6 million people die every year from this disease, 0.7–1 million of which are children aged less than 5 years.This book reports the outcome of a study to determine the clinical and cost burden of pneumococcal disease in Malaysia and to evaluate the economic impact of introducing Pneumococcal Vaccine in the National Immunisation Programme for the prevention of invasive and non-invasive pneumococcal diseases. A retrospective review of patient medical records from four public hospitals in Malaysia was conducted to quantify the cost and the number of paediatric and adult hospital admissions attributable to pneumococcal pneumonia, septicaemia, meningitis and acute otitis media. A total 2.3 million cases of pneumococcal diseases were estimated in Malaysian annually. The cost-effectiveness analysis using Markov cohort model predicted that the vaccine would to lead to a significant reduction in the incidence of all manifestations of pneumococcal diseases, and importantly will save lives of adults and children.

About the Author

Dr Syed Mohamed Aljunid is currently appointed as the Founding Professor in the Department of Health Policy and Management, Faculty of Public Health, Kuwait University. Prior to this he served as Professor of Health Economics and Public Health Medicine in National University of Malaysia and the International Centre for Casemix and Clinical Coding.